Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
JACC. Cardiovascular Interventions|January 2, 2022
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy CalcificationHideyuki Kawashima, Patrick W Serruys, Hironori Hara, et al.
Journal of the American College of Cardiology|November 10, 2022
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure RangeFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2025
Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distributionMick P L Renkens, Tsung-Ying Tsai, Pruthvi C Revaiah, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 13, 2016
Anatomical and procedural determinants of catheter-based renal denervationSebastian Ewen, Christian Ukena, Thomas Felix Lüscher, et al.
American Heart Journal|March 21, 2016
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trialMarko Banovic, Bernard Iung, Jozef Bartunek, et al.
BMJ Open|December 11, 2020
Safety and feasibility evaluation of planning and execution of surgical revascularisation solely based on coronary CTA and FFRCT in patients with complex coronary artery disease: study protocol of the FASTTRACK CABG studyHideyuki Kawashima, Giulio Pompilio, Daniele Andreini, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2026
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisationAsahi Oshima, Patrick W Serruys, Scot Garg, et al.
European Journal of Heart Failure|March 17, 2026
Long-term Safety and Performance of an Implantable IVC Sensor for Congestion-Guided Management in Heart Failure: 12-Month Results from the FUTURE-HF Trial PortfolioKevin Damman, Nir Uriel, Mandeep R Mehra, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
The American Journal of Cardiology|October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
Pageof 13